Avicenna Research Institute
Iran
Clinical Trials
11
Active:0
Completed:4
Trial Phases
4 Phases
Phase 1:2
Phase 2:1
Phase 3:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (54.5%)Phase 1
2 (18.2%)Phase 3
2 (18.2%)Phase 2
1 (9.1%)Menstrual Blood Stem Cells in Poor Ovarian Responders
Phase 3
Completed
- Conditions
- Poor Ovarian ResponseInfertility, Female
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- Avicenna Research Institute
- Target Recruit Count
- 180
- Registration Number
- NCT05703308
- Locations
- 🇮🇷
Avicenna Research Institute, Tehran, Iran, Islamic Republic of
Menstrual Blood Stem Cells in Severe Covid-19
Phase 1
Completed
- Conditions
- Covid19Cytokine Storm
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- Avicenna Research Institute
- Target Recruit Count
- 29
- Registration Number
- NCT05019287
- Locations
- 🇮🇷
Avicenna Research Institute, Tehran, Iran, Islamic Republic of
News
No news found